439 related articles for article (PubMed ID: 6310789)
1. [Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
Bégué P; Safran C; Fleurette J; Brun Y; Floret D; Monnet P
Sem Hop; 1983 Jun; 59(26):1972-6. PubMed ID: 6310789
[No Abstract] [Full Text] [Related]
2. [Clinical evaluation of moxalactam].
Acar JF
Sem Hop; 1983 Jun; 59(26):1990-3. PubMed ID: 6310793
[No Abstract] [Full Text] [Related]
3. Moxalactam therapy for bacterial infections.
Winston DJ; Busuttil RW; Kurtz TO; Young LS
Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
[TBL] [Abstract][Full Text] [Related]
4. Moxalactam in pediatrics.
Barson WJ; Nahata MC
Drug Intell Clin Pharm; 1982 Feb; 16(2):113-4. PubMed ID: 6210520
[No Abstract] [Full Text] [Related]
5. New drugs for enteric gram-negative bacillary meningitis in adults.
Med Lett Drugs Ther; 1981 Aug; 23(17):73-4. PubMed ID: 6267438
[No Abstract] [Full Text] [Related]
6. Moxalactam disodium (Moxam).
Med Lett Drugs Ther; 1982 Feb; 24(602):13-4. PubMed ID: 6460163
[No Abstract] [Full Text] [Related]
7. Moxalactam in the treatment of pediatric infections.
Yogev R; Schreiber M; Gardner S; Shulman ST
Am J Dis Child; 1982 Sep; 136(9):836-9. PubMed ID: 6214182
[TBL] [Abstract][Full Text] [Related]
8. [The French experience with moxalactam in pneumology].
Leng B; Imbert Y; Coomans D
Sem Hop; 1983 Jun; 59(26):1977-80. PubMed ID: 6310790
[TBL] [Abstract][Full Text] [Related]
9. [Clinical studies of 6059-S in the field of pediatrics (author's transl)].
Minamitani M; Hachimori K; Tomori N
Jpn J Antibiot; 1981 Apr; 34(4):608-17. PubMed ID: 6457169
[No Abstract] [Full Text] [Related]
10. New concepts in the management of infants and children with meningitis.
McCracken GH
Pediatr Infect Dis; 1983; 2(3 Suppl):S51-5. PubMed ID: 6306611
[No Abstract] [Full Text] [Related]
11. Cephalosporin antibiotics: therapeutic dimensions and future.
Benner EJ
Postgrad Med J; 1971 Feb; 47():Suppl:135-42. PubMed ID: 5556185
[No Abstract] [Full Text] [Related]
12. [Clinical and bacteriologic experimentation with cephradine in pediatrics].
Malherbe A
Brux Med; 1974 Feb; 54(2):99-103. PubMed ID: 4434245
[No Abstract] [Full Text] [Related]
13. Clinical and pharmacokinetic evaluation of moxalactam in infants and children.
Varghese M; Khan AJ; Quaye G; Patel U; Kumar K; Evans HE
Chemotherapy; 1982; 28(6):417-20. PubMed ID: 6218971
[TBL] [Abstract][Full Text] [Related]
14. The newest cephalosporins: how to use them?
Ehrenkranz NJ; Hoffman TA
J Fla Med Assoc; 1982 Oct; 69(10):863-4. PubMed ID: 6292322
[No Abstract] [Full Text] [Related]
15. Moxalactam: clinical summary of efficacy and safety.
Kammer RB
Rev Infect Dis; 1982; 4 Suppl():S712-9. PubMed ID: 6218589
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of 6059-S in children, particularly in the treatment of bacterial meningitis (author's transl)].
Kobayashi Y; Haruta T; Kuroki S; Okura K; Fujiwara T; Morikawa Y
Jpn J Antibiot; 1981 Apr; 34(4):587-98. PubMed ID: 6457167
[No Abstract] [Full Text] [Related]
17. [Clinical results and pharmacokinetics of 6059-S in the field of pediatrics (author's transl)].
Takimoto M; Kusunoki Y; Chou K; Yoshioka H; Sanae N; Maruyama S
Jpn J Antibiot; 1981 Apr; 34(4):545-50. PubMed ID: 6457162
[TBL] [Abstract][Full Text] [Related]
18. Third-generation cephalosporins: a critical evaluation.
Barriere SL; Flaherty JF
Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics, in vitro activity and clinical experience with lamoxactam].
Klech H; Fiser I
Schweiz Rundsch Med Prax; 1983 Mar; 72(11):369-78. PubMed ID: 6221244
[No Abstract] [Full Text] [Related]
20. [Septicemia and focal infection. Efficacy of moxalactam. Results of the cooperative study conducted in France].
Carbon C
Sem Hop; 1983 Jun; 59(26):1981-4. PubMed ID: 6310791
[No Abstract] [Full Text] [Related]
[Next] [New Search]
